The task assigned to the working group on Clinical Antimicrobial Trials for Primary and/or Secondary Prevention of Atherosclerotic Cardiovascular Disease was to evaluate the need for additional clinical antibiotic trials of a primary or secondary nature for the treatment of atherosclerotic heart disease and to suggest possible designs for future trials. In addition, the working group was to define the role of collaboration in answering research questions.
|Original language||English (US)|
|Journal||Journal of Infectious Diseases|
|Issue number||6 SUPPL. 3|
|State||Published - Jul 10 2000|
ASJC Scopus subject areas
- Immunology and Allergy
- Infectious Diseases